PLATELET-ACTIVATING FACTOR AND HYPERACUTE REJECTION
INDUCTION OF DONOR-SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI-CD4 MONOCLONAL ANTIBODY THERAPY
THE LIMITED EFFICACY OF CYCLOSPORINE IN PREVENTING REJECTION AND GRAFT-VERSUS-HOST DISEASE IN ORTHOTOPIC SMALL BOWEL TRANSPLANTATION IN RATS
ALTERATIONS IN PROTEOLYTIC ENZYMES OF THE PROXIMAL TUBULE IN A RAT MODEL OF CYCLOSPORINE NEPHROTOXICITY
THE SURVIVAL AND NATURE OF THE IMMUNE RESPONSE TO SOFT-TISSUE AND COMPOSITE-TISSUE ALLOGRAFTS IN RATS TREATED WITH LOW-DOSE CYCLOSPORINE
PURIFIED CANINE ISLET AUTOGRAFTS
PROTECTION OF ISLETS OF LANGERHANS FROM INTERLEUKIN-1 TOXICITY BY ARTIFICIAL MEMBRANES
SIGNIFICANCE OF PORTAL VENOUS DRAINAGE AFTER WHOLE-ORGAN PANCREAS TRANSPLANTATION FOR ENDOCRINE GRAFT FUNCTION AND PREVENTION OF DIABETIC NEPHROPATHY
THE QUALITY OF LIFE IN ADULT SURVIVORS OF ALLOGENEIC BONE MARROW TRANSPLANTATION
PREVENTION OF GRAFT REJECTION IN ALLOGENEIC BONE MARROW TRANSPLANTATION
T CELL DEPLETION WITH ANTI-CD5 IMMUNOTOXIN IN HISTOCOMPATIBLE BONE MARROW TRANSPLANTATION
DEVELOPMENT OF IgA DEFICIENCY AFTER BONE MARROW TRANSPLANTATION
SIX WEEKS OF CONTINUOUS INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE METHOTREXATE AS PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
MULTISCREEN SERUM ANALYSIS OF HIGHLY SENSITIZED RENAL DIALYSIS PATIENTS FOR ANTIBODIES TOWARD PUBLIC AND PRIVATE CLASS I HLA DETERMINANTS
THE IMPACT OF EXTENDED PRESERVATION ON CLINICAL LIVER TRANSPLANTATION
IMMUNOLOGICAL TOLERANCE IN HUMAN TRANSPLANTATION
AN UNEXPECTED EFFECT OF MATCHING FOR HLA-A9 IN RENAL TRANSPLANTATION
EFFECT OF PROTEIN A IMMUNOADSORPTION ON PANEL LYMPHOCYTE REACTIVITY IN HYPERIMMUNIZED PATIENTS AWAITING A KIDNEY GRAFT
EVIDENCE THAT HUMAN ORAL EPITHELIUM RECONSTITUTED IN VITRO AND TRANSPLANTED ONTO PATIENTS WITH DEFECTS IN THE ORAL MUCOSA RETAINS PROPERTIES OF THE ORIGINAL DONOR SITE1
TUMOR NECROSIS FACTOR, MACROPHAGE COLONY-STIMULATING FACTOR, AND INTERLEUKIN 1 PRODUCTION WITHIN SPONGE MATRIX ALLOGRAFTS1
HEPATOCYTE TRANSPLANTATION FOR THE LOW-DENSITY LIPOPROTEIN RECEPTOR-DEFICIENT STATEA
A NOVEL SYSTEM FOR TRANSPLANTATION OF ISOLATED HEPATOCYTES UTILIZING HBsAg-PRODUCING TRANSGENIC DONOR CELLS192
REJECTION OF PRIMARILY VASCULARIZED HEART GRAFTS
FAILURE OF RAT KIDNEY NEPHRON COMPONENTS TO INDUCE ALLOGENEIC LYMPHOCYTES TO PROLIFERATE IN MIXED LYMPHOCYTE KIDNEY CELL CULTURE
EVIDENCE THAT ALTERATIONS IN RENAL METABOLISM AND LIPID PEROXIDATION MAY CONTRIBUTE TO CYCLOSPORINE NEPHROTOXICITY
SPECIFIC UNRESPONSIVENESS IN RATS WITH PROLONGED CARDIAC ALLOGRAFT SURVIVAL AFTER TREATMENT WITH CYCLOSPORINE. IV. EXAMINATION OF T CELL SUBSETS IN GRAFT-VERSUS-HOST ASSAYS1
SELECTIVE EFFECT OF NONCYTOTOXIC BLOCKING ALLOANTIBODIES PRODUCED AFTER PLATELET TRANSFUSIONS ON MLC, AND MITOGEN AND SOLUBLE ANTIGEN-INDUCED RESPONSES OF HUMAN LYMPHOCYTES
A B CELL-SUPPRESSIVE IgG-ANTIIMMUNOGLOBULIN ANTIBODY INDUCED BY ALLOIMMUNIZATION
EVALUATION OF AMPHOTERICIN B—CYCLOSPORINE INTERACTION IN THE RAT
POSSIBLE RESUSCITATION OF LIVER FUNCTION BY HYPOTHERMIC REPERFUSION IN VITRO AFTER PROLONGED (24-HOUR) COLD PRESERVATION—A 31P NMR STUDY
AN EXPERIMENTAL STUDY OF PITUITARY TRANSPLANTATION
IMMUNODEFICIENCY AFTER TRANSPLANTATION OF ALLOANTIGEN-MATCHED BONE MARROW FROM AN IMMUNOREGULATORY MUTANT
SERUM TUMOR NECROSIS FACTOR ALPHA ASSOCIATED WITH ACUTE GRAFT-VERSUS-HOST DISEASE IN HUMANS
CYCLOSPORINE IN THE TREATMENT OF ACUTE VASCULAR REJECTION OF RENAL ALLOGRAFTS
AN ALTERNATIVE METHOD OF ASSESSMENT OF HLA INCOMPATIBILITIES IN KIDNEY GRAFTS
HETEROTOPIC LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE—A BRIDGE TO RECOVERY
POTENTIAL PITFALLS IN THE DETERMINATION OF AMYLASE ACTIVITY IN THE URINE OF PANCREAS-TRANSPLANTED PATIENTS WITH BLADDER DRAINAGE
IN VITRO HUMAN VERSUS MURINE XENOGENEIC REACTIONS
MODULATION OF ISCHEMIC LUNG INJURY BY CORTICOSTEROIDS
THE IMPORTANCE OF SERUM DITHIOTHERITOL TREATMENT IN CROSSMATCHING SELECTION OF PRESENSITIZED KIDNEY TRANSPLANT RECIPIENTS
INTRAPARTUM ORTHOTOPIC LIVER TRANSPLANTATION WITH SUCCESSFUL OUTCOME OF PREGNANCY
LIMITED USE OF MINOXIDIL IN RENAL TRANSPLANT RECIPIENTS BECAUSE OF THE ADDITIVE SIDE-EFFECTS OF CYCLOSPORINE ON HYPERTRICHOSIS